{"id":33844,"date":"2015-04-07T10:47:46","date_gmt":"2015-04-07T09:47:46","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/bmj\/?p=33844"},"modified":"2015-04-07T10:54:18","modified_gmt":"2015-04-07T09:54:18","slug":"the-bmj-today","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/bmj\/2015\/04\/07\/the-bmj-today\/","title":{"rendered":"The BMJ Today: Lucentis vs Avastin, teenagers with back pain, and a maternal blood test for Down’s syndrome"},"content":{"rendered":"

\u2022 \"amd\"<\/a>The BMJ<\/em>‘s investigation looking at why UK doctors have had difficulty prescribing the drug Avastin<\/a> to treat wet age related macular degeneration rather than the more expensive Lucentis has provoked some interesting responses<\/a>, including ones from Niall Dickson, chief executive of the General Medical Council<\/a>, and Stephen JW Evans, professor of pharmacoepidemiology<\/a> at the London School of Hygiene and Tropical Medicine.<\/p>\n

\u2022 In research news,\u00a0a large multi-centre, prospective study<\/a> published in the New England Journal of Medicine<\/em> has found that taking a blood sample from women at 10 to 14 weeks of pregnancy and analysing cell-free foetal DNA for an extra chromosome is more effective than standard non-invasive screening tests in diagnosing Down\u2019s syndrome.<\/p>\n

\"back_pain_teen\"<\/a>\u2022 In his 10 minute consultation, Adam D Jakes explains how “back pain in teenagers is common,”<\/a> and that “characterising the pain and identifying the presence of red flags are vital to ensuring that potentially serious conditions are identified.”<\/p>\n

\u2022 And finally, take a look at Jeffrey Aronson’s blog.<\/a> An interaction with a patient\u2014”That specialist registrar you referred me to was totally useless,\u201d said Pat. \u201cWhat an insolent shmuck. Doc, don\u2019t ever become a registrar\u201d\u2014caused him to look closely at the “sh” phoneme. I learnt a lot and had a good giggle.<\/p>\n

Sally Carter<\/strong> is lead technical editor for the education section.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

\u2022 The BMJ‘s investigation looking at why UK doctors have had difficulty prescribing the drug Avastin to treat wet age related macular degeneration rather than the more expensive Lucentis has provoked some interesting responses, including ones from Niall Dickson, chief executive of the General Medical Council, and Stephen JW Evans, professor of pharmacoepidemiology at the […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[5750],"tags":[],"class_list":["post-33844","post","type-post","status-publish","format-standard","hentry","category-the-bmj-today"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/33844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=33844"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/33844\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=33844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=33844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=33844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}